These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22525678)
1. Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta. Sung JY; Choi HC Biochem Biophys Res Commun; 2012 May; 421(3):599-604. PubMed ID: 22525678 [TBL] [Abstract][Full Text] [Related]
2. Acetylcholine-induced AMP-activated protein kinase activation attenuates vasoconstriction through an LKB1-dependent mechanism in rat aorta. Lee KY; Choi HC Vascul Pharmacol; 2013; 59(3-4):96-102. PubMed ID: 23916920 [TBL] [Abstract][Full Text] [Related]
3. Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway. Kim SG; Kim JR; Choi HC J Med Food; 2018 Feb; 21(2):146-153. PubMed ID: 29035613 [TBL] [Abstract][Full Text] [Related]
4. Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction. Hwang YJ; Cho DH Biochem Biophys Res Commun; 2020 Apr; 524(4):853-860. PubMed ID: 32046856 [TBL] [Abstract][Full Text] [Related]
6. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Sakamoto K; Göransson O; Hardie DG; Alessi DR Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958 [TBL] [Abstract][Full Text] [Related]
7. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway. Sung JY; Choi HC Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289 [TBL] [Abstract][Full Text] [Related]
8. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444 [TBL] [Abstract][Full Text] [Related]
9. Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate. Taylor EB; Ellingson WJ; Lamb JD; Chesser DG; Compton CL; Winder WW Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E661-9. PubMed ID: 16278246 [TBL] [Abstract][Full Text] [Related]
10. Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues. Kojima K; Motoshima H; Tsutsumi A; Igata M; Matsumura T; Kondo T; Kawashima J; Ichinose K; Furukawa N; Inukai K; Katayama S; Goldstein BJ; Nishikawa T; Tsuruzoe K; Araki E Biochem Biophys Res Commun; 2008 Nov; 376(2):434-8. PubMed ID: 18789895 [TBL] [Abstract][Full Text] [Related]
11. A role for Rho kinase in vascular contraction evoked by sodium fluoride. Jeon SB; Jin F; Kim JI; Kim SH; Suk K; Chae SC; Jun JE; Park WH; Kim IK Biochem Biophys Res Commun; 2006 Apr; 343(1):27-33. PubMed ID: 16527249 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice. Cao X; Luo T; Luo X; Tang Z Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Wang S; Liang B; Viollet B; Zou MH Hypertension; 2011 May; 57(5):1010-7. PubMed ID: 21464390 [TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle. Tsai MH; Jiang MJ Life Sci; 2005 Jan; 76(8):877-88. PubMed ID: 15589965 [TBL] [Abstract][Full Text] [Related]
15. Effects of 3',4'-dihydroxyflavonol on vascular contractions of rat aortic rings. Song MJ; Baek I; Seo M; Kim SH; Suk K; Woodman OL; Williams SJ; Kim IK Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):803-10. PubMed ID: 20374259 [TBL] [Abstract][Full Text] [Related]
16. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). Sauro MD; Thomas B J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773 [TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta. Shimomura E; Shiraishi M; Iwanaga T; Seto M; Sasaki Y; Ikeda M; Ito K Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):414-22. PubMed ID: 15459803 [TBL] [Abstract][Full Text] [Related]
19. Regulation of contractile activity in vascular smooth muscle by protein kinases. Silver PJ Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813 [TBL] [Abstract][Full Text] [Related]
20. Effects of a myosin light chain kinase inhibitor, wortmannin, on cytoplasmic Ca2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle. Takayama M; Ozaki H; Karaki H Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):120-7. PubMed ID: 8857588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]